Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Advanced Therapeutics|October 6, 2025
Enzyme-Based Synthetic Protein Nanoparticles as Colloidal AntioxidantsAva Mauser, Daniel F Quevedo, Boya Zhang, et al.Eneuro|August 15, 2024
Microtubule-Stabilizer Epothilone B Delays Anesthetic-Induced Unconsciousness in RatsSana Khan, Yixiang Huang, Derin Timuçin, et al.Clinical Lymphoma, Myeloma & Leukemia|December 27, 2023
The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health AdministrationGabriel Roman Souza, Zohra Nooruddin, Sophia Lee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1Paul Krogstad, Sophia Lee, George Johnson, et al.The Journal of Biological Chemistry|December 2, 2017
Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cellsTao Huang, Mary Mathieu, Sophia Lee, et al.The Pediatric Infectious Disease Journal|February 13, 2002
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infectionRam Yogev, Sophia Lee, Andrew Wiznia, et al.Advanced Therapeutics|November 22, 2024
Controlled Delivery of Paclitaxel via Stable Synthetic Protein NanoparticlesAva Mauser, Isabel Waibel, Kaushik Banerjee, et al.Mabs|March 2, 2018
Automated high throughput microscale antibody purification workflows for accelerating antibody discoveryPeng Luan, Sophia Lee, Tia A Arena, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|December 11, 2024
Enoxaparin 40mg Twice Daily with Peak Anti-Xa Adjustments is Safe and Necessary to Achieve Therapeutic Chemoprophylaxis in Burn-Injured PatientsDesiree N Pinto, Sophia Lee, Cory Johnson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.Pageof 5